Target intelligence / Profile preview

Intestinal flora homeostasis

Molecular classification
Other
01

Overview

Intestinal flora homeostasis refers to the optimal balance and functional diversity of microbial populations residing in the gastrointestinal tract, which is pivotal for digestion, nutrient absorption, metabolism, immune system development, and defense against pathogens. This equilibrium is influenced by genetics, diet, drugs, and environment. Disruption (dysbiosis) can lead to various diseases including inflammatory bowel disease, metabolic syndrome, infections, and neuropsychiatric disorders. The microbiota also play a key role in drug metabolism, with some drugs requiring microbial transformation to become active or inactive. Maintenance of homeostasis is thus central to health, and strategies to restore or support it include microbiota-targeted therapies (prebiotics, probiotics, microbiota-directed drugs).

Other names
gut microbiota homeostasismicrobiome homeostasisintestinal microbiota balance
02

Mechanism of action

Direct modulation of microbial composition (antibiotics, probiotics, prebiotics); microbial biotransformation of drugs (activation/inactivation via microbial metabolism); modulation of host immune and metabolic responses via microbial metabolites and signaling.

03

Biological functions

Immune responseMetabolic regulationBarrier integrity maintenanceNutrient synthesis and digestionProtection against pathogensModulation of inflammation
04

Disease associations

Inflammation (intestinal, systemic)InfectionCancerMetabolic disorderCardiovascular diseaseNeuropsychiatric disorders (anxiety, depression)Diabetes and obesity
05

Safety considerations

Dysbiosis-induced inflammationSusceptibility to infectionMetabolic derangements from altered microbiomeOff-target effects of antibiotics and microbiota-altering drugs
06

Interacting drugs

Antibiotics

4 more in the full profile.

07

Biomarkers

Microbial diversity indices (e.g., Shannon diversity)Relative abundance of key species (e.g., Faecalibacterium prausnitzii, Bifidobacterium)Fecal short-chain fatty acids (SCFAs: acetate, butyrate, propionate)Microbial gene sequencing (16S rRNA)

Beyond the preview

Go deeper on Intestinal flora homeostasis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal flora homeostasis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call